These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 29391830)

  • 1. Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.
    Omarini C; Guaitoli G; Pipitone S; Moscetti L; Cortesi L; Cascinu S; Piacentini F
    Cancer Manag Res; 2018; 10():91-103. PubMed ID: 29391830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology and Management of Patients With Triple-Negative Breast Cancer.
    Sharma P
    Oncologist; 2016 Sep; 21(9):1050-62. PubMed ID: 27401886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response.
    De Santis P; Perrone M; Guarini C; Santoro AN; Laface C; Carrozzo D; Oliva GR; Fedele P
    Explor Target Antitumor Ther; 2024; 5(1):232-250. PubMed ID: 38464390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors.
    Garufi G; Palazzo A; Paris I; Orlandi A; Cassano A; Tortora G; Scambia G; Bria E; Carbognin L
    Expert Opin Pharmacother; 2020 Apr; 21(6):687-699. PubMed ID: 32052646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements in the Treatment of Triple-Negative Breast Cancer: A Narrative Review of the Literature.
    Landry I; Sumbly V; Vest M
    Cureus; 2022 Feb; 14(2):e21970. PubMed ID: 35282535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic pattern and progress of neoadjuvant treatment for triple-negative breast cancer.
    Xiao Y; Gao W
    Oncol Lett; 2022 Jul; 24(1):219. PubMed ID: 35720488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial issues in the neoadjuvant treatment of triple-negative breast cancer.
    Fitzpatrick A; Tutt A
    Ther Adv Med Oncol; 2019; 11():1758835919882581. PubMed ID: 31700549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer.
    Tazzite A; Jouhadi H; Benider A; Nadifi S
    Curr Drug Targets; 2020; 21(10):962-973. PubMed ID: 32013831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer.
    Dixon-Douglas J; Loibl S; Denkert C; Telli M; Loi S
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-13. PubMed ID: 35649211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes.
    Diana A; Carlino F; Franzese E; Oikonomidou O; Criscitiello C; De Vita F; Ciardiello F; Orditura M
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
    Dixon-Douglas J; Loi S
    Curr Treat Options Oncol; 2023 Aug; 24(8):1004-1020. PubMed ID: 37222922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies.
    Gupta GK; Collier AL; Lee D; Hoefer RA; Zheleva V; Siewertsz van Reesema LL; Tang-Tan AM; Guye ML; Chang DZ; Winston JS; Samli B; Jansen RJ; Petricoin EF; Goetz MP; Bear HD; Tang AH
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32846967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple negative breast cancer: looking for the missing link between biology and treatments.
    Palma G; Frasci G; Chirico A; Esposito E; Siani C; Saturnino C; Arra C; Ciliberto G; Giordano A; D'Aiuto M
    Oncotarget; 2015 Sep; 6(29):26560-74. PubMed ID: 26387133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
    Lehmann BD; Jovanović B; Chen X; Estrada MV; Johnson KN; Shyr Y; Moses HL; Sanders ME; Pietenpol JA
    PLoS One; 2016; 11(6):e0157368. PubMed ID: 27310713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple-negative breast cancer: recent treatment advances.
    Bergin ART; Loi S
    F1000Res; 2019; 8():. PubMed ID: 31448088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.
    Agostinetto E; Losurdo A; Nader-Marta G; Santoro A; Punie K; Barroso R; Popovic L; Solinas C; Kok M; de Azambuja E; Lambertini M
    Expert Opin Investig Drugs; 2022 Jun; 31(6):567-591. PubMed ID: 35240902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the systemic treatment of triple-negative breast cancer.
    Lebert JM; Lester R; Powell E; Seal M; McCarthy J
    Curr Oncol; 2018 Jun; 25(Suppl 1):S142-S150. PubMed ID: 29910657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA Gene Mutations and Poly(ADP-Ribose) Polymerase Inhibitors in Triple-Negative Breast Cancer.
    Okuma HS; Yonemori K
    Adv Exp Med Biol; 2017; 1026():271-286. PubMed ID: 29282689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives.
    Carbognin L; Furlanetto J; Vicentini C; Nortilli R; Pilotto S; Brunelli M; Pellini F; Pollini GP; Bria E; Tortora G
    Anticancer Agents Med Chem; 2015; 15(1):15-25. PubMed ID: 25329488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?
    Gupta RK; Roy AM; Gupta A; Takabe K; Dhakal A; Opyrchal M; Kalinski P; Gandhi S
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.